Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Nichols

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factorD A Bellinger, T C Nichols, M S Read, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1990
von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosisT C Nichols, D A Bellinger, D A Tate, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimerasT C Nichols, C M Samama, D A Bellinger, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 25, 2002
Splenic clearance mechanisms of rehydrated, lyophilized plateletsT H Fischer, E Merricks, D A Bellinger, et al.
Blood|May 15, 1993
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia AT C Nichols, D A Bellinger, R L Reddick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 1998
von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stressT C Nichols, D A Bellinger, R L Reddick, et al.
Thrombosis and Haemostasis|April 20, 2001
Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogsK E Russell, M S Read, D A Bellinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia BT C Nichols, R A Raymer, H W G Franck, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusionM S Read, R L Reddick, A P Bode, et al.
The American Journal of Pathology|February 1, 1992
Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotypeT C Nichols, D A Bellinger, K E Davis, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factorD A Bellinger, T C Nichols, M S Read, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1990
von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosisT C Nichols, D A Bellinger, D A Tate, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimerasT C Nichols, C M Samama, D A Bellinger, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 25, 2002
Splenic clearance mechanisms of rehydrated, lyophilized plateletsT H Fischer, E Merricks, D A Bellinger, et al.
Blood|May 15, 1993
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia AT C Nichols, D A Bellinger, R L Reddick, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 4, 1998
von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stressT C Nichols, D A Bellinger, R L Reddick, et al.
Thrombosis and Haemostasis|April 20, 2001
Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogsK E Russell, M S Read, D A Bellinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia BT C Nichols, R A Raymer, H W G Franck, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusionM S Read, R L Reddick, A P Bode, et al.
The American Journal of Pathology|February 1, 1992
Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotypeT C Nichols, D A Bellinger, K E Davis, et al.
Pageof 6